NeuroOne Medical Technologies Corporation (NASDAQ: NMTC)

NeuroOne? CEO Dave Rosa Discusses Epilepsy Treatment Innovations on Today’s Marketplace. ? CEO Dave Rosa was featured on?Today’s Marketplace (TMP)?alongside Dr. Jessica Clark, DNP, RN, Dean of the College of Nursing at Creighton University. The discussion explored the latest advancements in epilepsy treatment and NeuroOne’s breakthrough OneRF??Ablation System. ? Read the full press release here: https://lnkd.in/g8BnQG-v ? #NeuroOne #NMTC

NeuroOne? Accelerates Timeline of 510(k) Submission to FDA for the OneRF? Trigeminal Nerve Ablation System to Treat Facial Pain. Submission for New Intended Use That Leverages Company’s Patented OneRF? Technology Platform Expected in May 2025. ? Read the full press release here: https://lnkd.in/g8MS_Chh

NeuroOne? to Present at the Oppenheimer 35th Annual Healthcare MedTech & Services Conference. NeuroOne CEO Dave Rosa will deliver a virtual corporate presentation on March 19, 2025, at 9:20 a.m. ET, followed by one-on-one meetings. Join live or watch the replay here: https://lnkd.in/g9pVikhx #NeuroOne?#NMTC

In March, we raise awareness for traumatic brain injuries. Let's support survivors and work towards prevention. #TBIawareness

In March, we raise awareness for traumatic brain injuries. Let's support survivors and work towards prevention. #TBIawareness

Happy?Presidents?Day?from?NeuroOne! ? #nmtc #nmtc1 #nasdaq #neuroone NeuroOne Medical Technologies Corporation (NASDAQ: NMTC)

Celebrating leadership and progress on Presidents Day! Today, we honor those who have shaped our nation's history. #PresidentsDay

NeuroOne is excited to announce that our OneRF? ablation system was featured on Good Morning America (GMA) – ABC Network on February 12. Please check out the segment: Brain implant transforms teenage girl’s life. ? GMA shares the inspiring story of a teen who found hope after struggling with seizures for years, thanks to a groundbreaking new treatment. - https://lnkd.in/gfnQ3mgn ? Experience shared may not be representative of everyone’s outcomes, and outcomes can vary based on each individual’s circumstances. ? #N1MTC #NeuroOne #Neurosurgery #SEEG #EpilepsySurgery #Epilepsy

NeuroOne? Reports First Quarter Fiscal Year 2025 Financial Results and Provides Corporate Update. Product revenue increased 235% to $3.3 million in the first quarter of fiscal year 2025, compared to $1.0 million in the first quarter of fiscal 2024. ? Link to PR:?https://lnkd.in/gV_mCReQ #NeuroOne #NMTC

Our CEO, Dave Rosa, shares NeuroOne’s journey on the Nano Cap Podcast! From epilepsy treatment advancements to going public and key partnerships—don’t miss this insightful discussion. Listen here: https://lnkd.in/ez6FciHR